Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Colorectal cancer is the fourth most commonly diagnosed cancer among adults in the United States. Currently, the U.S. Preventive Services Task Force (USPSTF) recommends routine screening for adults ages 50 to 75.

However, the American Cancer Society recently modified their recommendation to begin at age 45 for those with average risk. The guideline was changed based in part on new data showing increased rates of colorectal cancer in younger populations.

Companies like Clinical Genomics are focused on improving the sensitivity and accuracy of screening tests, as well as providing options that may lead to early detection of residual and recurrent colorectal cancer in patients who have undergone primary treatment.

We get the facts from Dr. Roberto Rodriguez-Ruesga, a colon and rectal surgeon at Texas Oncology, and hear one woman’s personal story of being diagnosed with colon cancer at only 43 years old.

BioTE Medical is a leader in precision and preventive medicine. They create patient-centric strategies that optimize hormones for women and men.

The Oxford Gold Group was founded on the belief that everyone should have the opportunity to afford and benefit from owning precious metals. They tailor investment strategies for each investor based on their specific needs.

TruSculpt iD and truSculpt flex offer you a total body solution to remove fat, renew skin, and rebuild muscle.

Comments

comments